CP-103

N/A

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameCP-103
Drug Alias NameQuetiapine long acting injectionCP-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 antagonistsSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists +[5] 
TargetsAdrenergic receptors alpha-2Serotonin 2a (5-HT2a) receptorDopamine D2 receptor +[5] 
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConsegna Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesConsegna Pharma Inc
Inactive CompaniesN/A
Active IndicationsPsychotic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A